ARI0002h (cesnicabtagene Autoleucel), an Academic Point-of-Care B-Cell Maturation Antigen (Bcma)-Directed Chimeric Antigen Receptor (CAR) T-Cell Strategy: Activity and Safety after Fractionated Initial Therapy and Booster Dose in 60 Patients with Relapsed/Refractory Multiple Myeloma
Aina Oliver-Caldes,Veronica Gonzalez-Calle,Valentin Cabanas,Nieves Lopez-Munoz,Paula Rodriguez Otero,Juan Luis Reguera,Marta Espanol-Rego,Susana Inoges,Aintzane Zabaleta,Lucia Lopez Corral,Beatriz Martin-Antonio,Lorena Perez-Amill,Bruno Paiva,Laura Rosinol,Ascension Lopez-Diaz De Cerio,Sergio Navarro,Joan Cid,Natalia Tovar,Joaquin Saez-Penataro,Miriam Lopez Parra,Eulalia Olesti,Elena Guillen,Sara Varea,Julio Delgado,Jose Maria Sanchez Pina,Anthony Battram,Marta Sonia Gonzalez Perez,Andres Sanchez Salinas,Valentin Ortiz-Maldonado,Felipe Prosper,Manel Juan,Joaquin Martinez Lopez,Jose Maria Moraleda,Maria Victoria Mateos,Mariona Pascal,Alvaro Urbano-Ispizua,Carlos Fernandez de larrea Blood（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper